Libromide 325mg 100 pack

se as an adjunct to phenobarbital in the control of refractory cases of epilepsy in dogs. Contraindications Do not use in cases of known hypersensitivity to bromide, or to any of the excipients. Do not use in dogs with severe renal insufficiency. Special warnings for each target species It is advisable not to change the dog’s diet during therapy due to the effect of chloride intake on serum bromide concentrations, see Interactions. Special precautions for use in animals Do not abruptly discontinue therapy as this may precipitate seizures. In renal insufficiency, excretion of bromide is reduced. To prevent bromide accumulation, and a relative overdose of potassium bromide (see Overdose) administer a reduced dose of Libromide and monitor the serum bromide concentration closely. A reduction in chloride intake could cause bromide intoxication (see Interactions). Administration on an empty stomach may induce vomiting. Dogs weighing less than 11 kg cannot be accurately dosed with the recommended initial dose rate of 15 mg/kg twice daily as the minimum dose achievable by division of the Libromide 325 mg tablet is 162.5 mg, see Amounts to be administered and administration route. Potentially severe side effects can be associated with the use of potassium bromide in cats. Special precautions to be taken by the person administering the veterinary medicinal product to animals Do not handle this product if you are pregnant, think you are pregnant or if you are breast feeding. Do not handle this product if you have a known sensitivity to bromide. Wash hands thoroughly immediately after breaking or handling any tablets. Discontinue handling this product if you develop any signs of skin irritation, including itchiness, rash, peeling or flaking of skin or redness. In case of irritation of the skin or eyes, or in case of accidental self administration, seek medical advice immediately and show the package leaflet or the label to the physician. To the physician: Bromide intoxication can be treated by administration of sodium chloride or a suitable chloruretic agent. Adverse reactions Dogs receiving potassium bromide in combination with phenobarbital will commonly exhibit elevated serum pancreatic lipase immunoreactivity concentrations (cPLI) which may or may not be associated with clinical signs of pancreatitis. In cases of pancreatitis or dermatitis, symptomatic treatment may be required. Uncommon adverse reactions also include behavioural changes such as irritability or restlessness. Adverse clinical signs which may appear in dogs on higher doses of therapy usually disappear following a reduction in dose. If the dog is too sedated, assess the serum concentrations of both bromide and phenobarbital to determine whether the dose of either should be reduced. If the dose is reduced, measure the serum bromide concentration to ensure it remains within the therapeutic range. Commonly reported adverse reactions include polyuria/polydipsia, polyphagia, vomiting, somnolence, ataxia (hind end weakness and loss of coordination), nausea and erythematous dermatitis (bromide rash). In rare cases transient diarrhoea may occur. Haemorrhagic diarrhoea, pancreatitis, anorexia, hepatopathy, dyspnoea and vocalisation may appear very rarely. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports). Use during pregnancy and lactation The safety of the veterinary medicinal product has not been established during pregnancy or lactation in dogs. Although there was no evidence of reproductive toxicity in laboratory animals, bromide can cross the placenta and cases of neonatal bromide toxicity have been reported in humans. In the absence of specific data, continued use during pregnancy should be subject to a benefit/risk assessment by the responsible veterinarian. Since bromide may be excreted into milk, monitor nursing puppies for somnolence/sedative effects; if necessary, consider early weaning, or an artificial suckling method. Interactions Bromide and chloride compete for re-absorption by the kidneys. Increasing dietary chloride (salt) intake will decrease renal re-absorption of bromide, causing decreased serum bromide concentrations, which could lead to seizures. Conversely, changing to a diet low in chloride will increase serum bromide concentrations, which could cause bromide intoxication (see Overdose). Loop diuretics (e.g. furosemide) can increase bromide excretion, lowering serum bromide concentrations. Administration of fluids or drug formulations containing chloride can lower serum bromide concentrations. Bromide is synergistic with other GABA-ergic drugs such as phenobarbital.